Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT01123304
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed AJCC Stage IIIB, IIIC or IV melanoma with injectable metastases (in transit, intradermal, or subcutaneous nodules)
* Tumor accessible to intra-tumoral injections
* Cumulative tumor volume great enough to accept MORAb-028 injections for a given dose level, based on intent to inject at a concentration of 1 mg/cm3
Exclusion Criteria:
* Are candidates for curative surgical excision or lymphadenectomy
* Prior non-surgical treatment within 4 weeks
* Known central nervous system (CNS) tumor involvement or metastases
* Hypersensitivity to MORAb-028
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01123304
Study Brief:
Protocol Section:
NCT01123304